Caldera Therapeutics
Leading the march to IBD bispecifics
Boston, United States · Founded 2025 · $112.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- calderatx.com
- Total Funding
- $112.5M
- Last Round
- $37.5M Series AJan 2026
- Rounds
- 2
About
Caldera Therapeutics is a clinical-stage biotechnology company founded in 2025 and headquartered in Massachusetts, developing CLD-423, a first-in-class bispecific antibody targeting the IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic conditions. The company was built around a senior leadership team with deep IBD drug development experience, including CEO Praveen Tipirneni, formerly of Morphic Therapeutic. Caldera licensed CLD-423 from a Chinese partner and launched with $112.5 million in total funding from top biotech investors including Atlas Venture, LAV, venBio, Omega Funds, Wellington Management, and Janus Henderson. A Phase 1 healthy volunteer trial of CLD-423 is currently ongoing.
Summary
Caldera Therapeutics is a Biotech company based in Boston, United States, founded in 2025. It has raised $112.5M in total across 2 rounds, most recently a $37.5M Series A round in Jan 2026. Investors include Omega Funds, Atlas Venture and Wellington Management.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2026
Sign up to see all 2 rounds
Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/caldera-therapeutics"><img src="https://indexed.vc/api/badge/company/caldera-therapeutics" alt="Caldera Therapeutics on Indexed.vc" width="260" height="76" /></a>